This summary covers recent events in the health sector, including legal actions by Novo Nordisk against drug compounders, U.S. tariffs on pharma imports announced by Trump, Ypsomed’s production moves, and a severe water crisis in Gaza. It also highlights CEO changes and tariff challenges in the pharmaceutical industry.
